Renalytix Plc (AIM: RENX)
Health Care · Health Care Technology · GB
£0.05
+0.94% today · -41.1% 1Y
Renalytix Plc (AIM: RENX) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $42.35M.
Over the last twelve months the share price has lost 41.1%, trading between 0.02 and 0.10.
Tweenvest scores Renalytix Plc across four factors: quality 20/100, value 70/100. Its strongest factor is value.
RENX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.35M
- Revenue (TTM)
- $3.30M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 1.61
- 52-week high
- £0.10
- 52-week low
- £0.02
- Avg volume (3M)
- —
- Shares outstanding
- 603.83M
- Employees
- —
- Next earnings
- —
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MeVis Medical Solutions AGXTRA: M3V | $45.65M | €21.80 | -2.68% |
| DEEPNOID Inc.KOSDAQ: A315640 | $45.23M | ₩2,070.00 | -6.33% |
| BIT Computer Co., LtdKOSDAQ: A032850 | $43.98M | ₩3,890.00 | -6.83% |
| Acer Medical Inc.TPEX: 6857 | $43.09M | NT$90.50 | +0.33% |
| SUSMED,Inc.TSE: 4263 | $41.94M | ¥395.00 | -6.40% |
| Mentice AB (publ)OM: MNTC | $41.77M | Skr15.10 | +1.68% |
| DIAGNOS Inc.TSXV: ADK | $40.57M | CA$0.47 | -3.12% |
| Rocket Doctor AI Inc.CNSX: AIDR | $39.63M | CA$0.57 | -3.39% |
Figures last refreshed Oct 11, 2026.